In this feature, we look at the benefits of globally authorized monoclonal antibody treatments, along…
View More COVID-19: What is monoclonal antibody therapy?
Home »
COVID-19: Allergic reactions to Pfizer vaccine are rare
Researchers estimate a rate of 11.1 cases of anaphylaxis for every million first doses of…
View More COVID-19: Allergic reactions to Pfizer vaccine are rare
COVID-19: How do inactivated vaccines work?
Inactivated vaccines use a pathogen that has been modified so that it cannot replicate to…
View More COVID-19: How do inactivated vaccines work?
Analysis of patient data reveals most common complications of COVID-19
Researchers have analyzed the data of more than 70,000 people with COVID-19 in the United…
View More Analysis of patient data reveals most common complications of COVID-19
Many parents want to celebrate Thanksgiving with others despite risk
A new poll has found that parents are weighing up the potential risks and benefits…
View More Many parents want to celebrate Thanksgiving with others despite risk
What will the US election mean for older adults' (mental) health?
Briana Mezuk, Ph.D., is an associate professor in the Department of Epidemiology at the University…
View More What will the US election mean for older adults' (mental) health?
Tests may miss more than 1 in 5 COVID-19 cases
A team from Johns Hopkins Medicine has found that PCR-based tests for SARS-CoV-2 have a…
View More Tests may miss more than 1 in 5 COVID-19 cases
Could a novel UV light device inactivate SARS-CoV-2 on surfaces?
Physicists have found a way to make powerful UV LEDs that they believe manufacturers could…
View More Could a novel UV light device inactivate SARS-CoV-2 on surfaces?
WHO launch trial testing 4 potential treatments for COVID-19
The World Health Organization (WHO) have launched SOLIDARITY, a giant trial, testing the potential of…
View More WHO launch trial testing 4 potential treatments for COVID-19